SciClone to Host a Conference Call December 14, 2005 to Discuss ZADAXIN Phase 3 Hepatitis C Results and Interi (Hep C)

SciClone to Host a Conference Call December 14, 2005 to Discuss ZADAXIN Phase 3 Hepatitis C Results and Interi
Market Wire - announced that it will report ZADAXIN phase 3 hepatitis C results and interim phase 2 malignant melanoma data evaluated in two phase 3 hepatitis C clinical trials in the United

Gen-Probe to test blood for West Nile S.D. biotech approved for donor screening
SignOn San Diego - San Diego biotechnology company best known for HIV and Hepatitis C screening tests that are widely used to safeguard the